Highlights
NASDAQ: ENTA       Enanta Pharmaceutica
Last Price Today's Change   Day's Range   Trading Volume
65.66   +1.40 (2.18%)  64.28 - 65.73  150,754

Overview

 
Avg Volume (4 weeks):200,047
4 Weeks Range:58.00 - 65.73
4 Weeks Price Volatility (%):
99.09%
52 Weeks Range:57.15 - 106.80
52 Weeks Price Volatility (%):
17.14%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Enanta Pharmaceuticals Inc is an American biotechnology company focused on research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are: hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of the company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company’s inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

  Be the first to like this.
 


 

3640  2100  313  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.037 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers